Tvardi Therapeutics (TVRD) Payables (2013 - 2026)
Tvardi Therapeutics (TVRD) posted Payables of $4.6 million for Q1 2026, up 43.52% sequentially from $3.2 million in Q4 2025, and up 285.32% YoY from $1.2 million in Q1 2025.
Tvardi Therapeutics (TVRD) Payables (2013 - 2026) Analysis & Trends
Tvardi Therapeutics has reported Payables for 13 years, with the latest figure at $4.6 million in Q1 2026.
- Quarterly Payables rose 285.32% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (up 285.32% YoY) and the FY2025 annual result came in at $3.2 million, up 47.26% from the prior year.
- Payables advanced to $4.6 million in Q1 2026 per TVRD's latest filing, from $3.2 million in the prior quarter.
- Over five years, Payables peaked at $26.3 million in Q3 2022 and troughed at $1.2 million in Q1 2025.
- A 5-year average of $12.6 million and a median of $13.7 million in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2024: Payables soared 390.15% in 2022, then sank 91.46% in 2024.
- Over 5 years, Payables stood at $21.5 million in 2022, then advanced by 18.81% to $25.6 million in 2023, then tumbled by 91.46% to $2.2 million in 2024, then soared by 47.26% to $3.2 million in 2025, then surged by 43.52% to $4.6 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $4.6 million, $3.2 million, and $4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Tvardi Therapeutics | 17.36 Mn | 17.36 Mn | - | 4.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.62 Mn |
| Dec 31, 2025 | 3.22 Mn |
| Sep 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 2.43 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Sep 30, 2024 | 6.62 Mn |
| Jun 30, 2024 | 13.73 Mn |
| Mar 31, 2024 | 4.98 Mn |
| Dec 31, 2023 | 25.59 Mn |
| Sep 30, 2023 | 22.38 Mn |
| Jun 30, 2023 | 24.48 Mn |
| Mar 31, 2023 | 15.22 Mn |
| Dec 31, 2022 | 21.54 Mn |
| Sep 30, 2022 | 26.32 Mn |
| Jun 30, 2022 | 19.33 Mn |
| Mar 31, 2022 | 16.50 Mn |
| Dec 31, 2021 | 15.86 Mn |
| Sep 30, 2021 | 5.37 Mn |
| Jun 30, 2021 | 13.49 Mn |